Resveratrol levels and all-cause mortality in older community-dwelling adults
- PMID: 24819981
- PMCID: PMC4346286
- DOI: 10.1001/jamainternmed.2014.1582
Resveratrol levels and all-cause mortality in older community-dwelling adults
Abstract
Importance: Resveratrol, a polyphenol found in grapes, red wine, chocolate, and certain berries and roots, is considered to have antioxidant, anti-inflammatory, and anticancer effects in humans and is related to longevity in some lower organisms.
Objective: To determine whether resveratrol levels achieved with diet are associated with inflammation, cancer, cardiovascular disease, and mortality in humans.
Design: Prospective cohort study, the Invecchiare in Chianti (InCHIANTI) Study ("Aging in the Chianti Region"), 1998 to 2009 conducted in 2 villages in the Chianti area in a population-based sample of 783 community-dwelling men and women 65 years or older.
Exposures: Twenty-four-hour urinary resveratrol metabolites.
Main outcomes and measures: Primary outcome measure was all-cause mortality. Secondary outcomes were markers of inflammation (serum C-reactive protein [CRP], interleukin [IL]-6, IL-1β, and tumor necrosis factor [TNF]) and prevalent and incident cancer and cardiovascular disease.
Results: Mean (95% CI) log total urinary resveratrol metabolite concentrations were 7.08 (6.69-7.48) nmol/g of creatinine. During 9 years of follow-up, 268 (34.3%) of the participants died. From the lowest to the highest quartile of baseline total urinary resveratrol metabolites, the proportion of participants who died from all causes was 34.4%, 31.6%, 33.5%, and 37.4%, respectively (P = .67). Participants in the lowest quartile had a hazards ratio for mortality of 0.80 (95% CI, 0.54-1.17) compared with those in the highest quartile of total urinary resveratrol in a multivariable Cox proportional hazards model that adjusted for potential confounders. Resveratrol levels were not significantly associated with serum CRP, IL-6, IL-1β, TNF, prevalent or incident cardiovascular disease, or cancer.
Conclusions and relevance: In older community-dwelling adults, total urinary resveratrol metabolite concentration was not associated with inflammatory markers, cardiovascular disease, or cancer or predictive of all-cause mortality. Resveratrol levels achieved with a Western diet did not have a substantial influence on health status and mortality risk of the population in this study.
Conflict of interest statement
The authors have no conflicts of interest.
Comment in
-
Do not throw out the resveratrol with the bath water.JAMA Intern Med. 2015 Jan;175(1):140-1. doi: 10.1001/jamainternmed.2014.7000. JAMA Intern Med. 2015. PMID: 25560944 No abstract available.
-
Effect of wine consumption on mortality.JAMA Intern Med. 2015 Apr;175(4):650. doi: 10.1001/jamainternmed.2014.8068. JAMA Intern Med. 2015. PMID: 25844739 No abstract available.
-
Effect of wine consumption on mortality--reply.JAMA Intern Med. 2015 Apr;175(4):651. doi: 10.1001/jamainternmed.2014.8078. JAMA Intern Med. 2015. PMID: 25844742 No abstract available.
References
-
- Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ, Belvisi MG. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J. 2005;19:840–841. - PubMed
-
- Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006;72:1439–1352. - PubMed
-
- Tomé-Carneiro J, Gonzálvez M, Larrosa M, et al. Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci. 2013;1290:37–51. - PubMed
-
- Wu JM, Hsieh TC. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci. 2011;1215:16–21. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
